Reaktionsgleichung
C[O:2][C:3](=[O:19])[C@@H:4]([NH2:18])[CH2:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)=[CH:8][CH:7]=1.[Br:20][C:21]1[CH:30]=[C:29]2[C:24]([CH:25]=[C:26]([C:31](O)=[O:32])[N:27]=[CH:28]2)=[CH:23][CH:22]=1>>[C:9]1([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=2)[CH:10]=[CH:11][C:6]([CH2:5][C@H:4]([NH:18][C:31]([C:26]2[N:27]=[CH:28][C:29]3[C:24]([CH:25]=2)=[CH:23][CH:22]=[C:21]([Br:20])[CH:30]=3)=[O:32])[C:3]([OH:2])=[O:19])=[CH:7][CH:8]=1Komponenten
3
Versuchsvorschrift
(2S)-amino-3-biphenyl-4yl-propionic acid methyl ester (340 mg, 13.9 mmol) was reacted with 7-bromo-isoquinoline-3-carboxylic acid (350 mg, 13.9 mmol) as described in general procedure A. The resulting compound was hydrolyzed by following general procedure C yielding the title compound (132 mg, 81%) as a white solid.
Quellen und Nachweise
- ORD-Eintrag
- ord-df615ce932de4adeaa72e423034d4e63
- Quelldatensatz
- uspto-grants-2006_10
- Patentnummer
- US07122580B2
Verknüpfte Notizen
Wird geladen…